GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. https://doi.org/10.1056/NEJMoa1614362.

Article  Google Scholar 

World Health Organization. Obesity and overweight; 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 10 Feb 2022

Google Scholar 

Fryar CD, Carroll MD, Ogden CL. Prevalence of overweight, obesity, and severe obesity among children and adolescents aged 2–19 years: United States, 1963–1965 through 2015–2016; 2018. https://www.cdc.gov/nchs/data/hestat/obesity_child_15_16/obesity_child_15_16.pdf. Accessed 8 Mar 2022

Google Scholar 

Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673–89. https://doi.org/10.1007/s40273-014-0243-x.

Article  Google Scholar 

Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S–1S. https://doi.org/10.1093/jn/127.5.990S.

Article  CAS  Google Scholar 

Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. https://doi.org/10.1093/ageing/afy169.

Article  Google Scholar 

Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56. https://doi.org/10.1016/j.jamda.2011.01.003.

Article  Google Scholar 

Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010;29(2):154–9. https://doi.org/10.1016/j.clnu.2009.12.004.

Article  CAS  Google Scholar 

Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) code. J Am Med Dir Assoc. 2016;17(8):675–7. https://doi.org/10.1016/j.jamda.2016.06.001.

Article  Google Scholar 

Khadra D, Itani L, Tannir H, et al. Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis. World J Diabetes. 2019;10(5):311–23. https://doi.org/10.4239/wjd.v10.i5.311.

Article  Google Scholar 

Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15(3):321–35. https://doi.org/10.1159/000521241.

Article  Google Scholar 

Schrager MA, Metter EJ, Simonsick E, et al. (2007) Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 1985;102(3):919–25. https://doi.org/10.1152/japplphysiol.00627.2006.

Article  Google Scholar 

Correa-de-Araujo R, Addison O, Miljkovic I, et al. Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging. Front Physiol. 2020;11:963. https://doi.org/10.3389/fphys.2020.00963.

Article  Google Scholar 

Rubio-Ruiz ME, Guarner-Lans V, Perez-Torres I, Soto ME. Mechanisms underlying metabolic syndrome-related sarcopenia and possible therapeutic measures. Int J Mol Sci. 2019;20(3):647. https://doi.org/10.3390/ijms20030647.

Article  CAS  Google Scholar 

Donini LM, Busetto L, Bauer JM, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr. 2020;39(8):2368–88. https://doi.org/10.1016/j.clnu.2019.11.024.

Article  Google Scholar 

Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and nutrition examination survey III. PLoS One. 2010;5(5):e10805. https://doi.org/10.1371/journal.pone.0010805.

Article  CAS  Google Scholar 

Farmer RE, Mathur R, Schmidt AF, et al. Associations between measures of sarcopenic obesity and risk of cardiovascular disease and mortality: a cohort study and Mendelian randomization analysis using the UK biobank. J Am Heart Assoc. 2019;8(13):e011638. https://doi.org/10.1161/JAHA.118.011638.

Article  Google Scholar 

Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253–60. https://doi.org/10.1111/jgs.12652.

Article  Google Scholar 

Roh E, Choi KM. Health consequences of sarcopenic obesity: a narrative review. Front Endocrinol (Lausanne). 2020;11:332. https://doi.org/10.3389/fendo.2020.00332.

Article  Google Scholar 

Baumgartner RN, Wayne SJ, Waters DL, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004;12(12):1995–2004. https://doi.org/10.1038/oby.2004.250.

Article  Google Scholar 

Sayer AA, Syddall HE, Martin HJ, et al. Is grip strength associated with health-related quality of life? Findings from the Hertfordshire cohort study. Age Ageing. 2006;35(4):409–15. https://doi.org/10.1093/ageing/afl024.

Article  Google Scholar 

Lee YH, Jung KS, Kim SU, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008-2011). J Hepatol. 2015;63(2):486–93. https://doi.org/10.1016/j.jhep.2015.02.051.

Article  Google Scholar 

Lee YH, Kim SU, Song K, et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). Hepatology. 2016;63(3):776–86. https://doi.org/10.1002/hep.28376.

Article  CAS  Google Scholar 

Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548. https://doi.org/10.1371/journal.pone.0169548.

Article  CAS  Google Scholar 

Gao Q, Mei F, Shang Y, et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr. 2021;40(7):4633–41. https://doi.org/10.1016/j.clnu.2021.06.009.

Article  Google Scholar 

Tyrovolas S, Koyanagi A, Olaya B, et al. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study. J Cachexia Sarcopenia Muscle. 2016;7(3):312–21. https://doi.org/10.1002/jcsm.12076.

Article  Google Scholar 

Baker JF, Harris T, Rapoport A, et al. Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity. J Cachexia Sarcopenia Muscle. 2020;11(6):1580–9. https://doi.org/10.1002/jcsm.12613.

Article  Google Scholar 

Batsis JA, Mackenzie TA, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and nutrition examination surveys 1999-2004. Nutr Res. 2015;35(12):1031–9. https://doi.org/10.1016/j.nutres.2015.09.003.

Article  CAS  Google Scholar 

Du K, Goates S, Arensberg MB, Pereira S, Gaillard T. Prevalence of sarcopenia and sarcopenic obesity vary with race/ethnicity and advancing age. Divers Equal Health Care. 2018;15(4):175–83.

Article  Google Scholar 

Wijarnpreecha K, Aby ES, Ahmed A, Kim D. Association between sarcopenic obesity and nonalcoholic fatty liver disease and fibrosis detected by Fibroscan. J Gastrointestin Liver Dis. 2021;30(2):227–32. https://doi.org/10.15403/jgld-3323.

Article  Google Scholar 

Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513–37. https://doi.org/10.1038/s41574-018-0062-9.

Article  Google Scholar 

Barazzoni R, Bischoff S, Boirie Y, et al. Sarcopenic obesity: time to meet the challenge. Obes Facts. 2018;11(4):294–305. https://doi.org/10.1159/000490361.

Article  Google Scholar 

Centers for Disease Control and Prevention National Health and Nutrition Examination Survey: Methods and Analytic Guidelines. https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. Accessed 17 Jan 2022

Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58. https://doi.org/10.1093/gerona/glu010.

Article  Google Scholar 

Cawthon PM, Peters KW, Shardell MD, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69(5):567–75. https://doi.org/10.1093/gerona/glu023.

Article  Google Scholar 

Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical Care of Patients with obesity. Endocr Pract. 2016;22(Suppl 3):1–203. https://doi.org/10.4158/EP161365.GL.

Article  Google Scholar 

Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62. https://doi.org/10.1210/jc.2014-3415.

Article  CAS  Google Scholar 

Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38. https://doi.org/10.1161/01.cir.0000437739.71477.ee.

Article  Google Scholar 

Koopman RJ, Mainous AG 3rd, Diaz VA, Geesey ME. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med. 2005;3(1):60–3. https://doi.org/10.1370/afm.214.

Article  Google Scholar 

Centers for Disease Control and Prevention NHANES 1999-2006 DXA multiple imputation data files. https://wwwn.cdc.gov/nchs/nhanes/dxa/dxa.aspx. Accessed 10 Feb 2022

Levine ME, Crimmins EM. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity (Silver Spring). 2012;20(10):2101–6. https://doi.org/10.1038/oby.2012.20.

Article  CAS  Google Scholar 

Yasuoka M, Muraki I, Imano H, et al. Joint impact of muscle mass and waist circumference on type 2 diabetes in Japanese middle-aged adults: The Circulatory Risk in Communities Study (CIRCS). J Diabetes. 2020;12(9):677–85. https://doi.org/10.1111/1753-0407.13049.

Article  CAS  Google Scholar 

Son JW, Lee SS, Kim SR, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia. 2017;60(5):865–72. https://doi.org/10.1007/s00125-016-4196-9.

Article  Google Scholar 

Bellafronte NT, de Queiros Mattoso Ono A, Chiarello PG. Sarcopenic obesity in chronic kidney disease: challenges in diagnosis using different diagnostic criteria. Med Princ Pract. 2021;30(5):477–86. https://doi.org/10.1159/000517597.

Article  Google Scholar 

Dierkes J, Dahl H, Lervaag Welland N, et al. High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy - an observational cross-sectional study. BMC Nephrol. 2018;19(1):259. https://doi.org/10.1186/s12882-018-1055-6.

Article  CAS  Google Scholar 

Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56(4):1010–3. https://doi.org/10.2337/db06-1656.

Article  CAS  Google Scholar 

Waters DL, Qualls CR, Dorin RI, Veldhuis JD, Baumgartner RN. Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes. J Gerontol A Biol Sci Med Sci. 2008;63(5):536–41. https://doi.org/10.1093/gerona/63.5.536.